Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
139 studies found for:    "Choreatic Disorders" OR "chorea-acanthocytosis" OR "Chorea, Hereditary" OR "Choreatic Syndrome" OR "Neuroacanthocytosis" OR "Chorea, Chronic Progressive" OR "Chronic Progressive Chorea"
Show Display Options
Rank Status Study
21 Active, not recruiting Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease
Condition: Huntington Disease
Intervention: Drug: pridopidine
22 Active, not recruiting Neurobiological Predictors of Huntington's Disease (PREDICT-HD)
Condition: Huntington Disease
Intervention:
23 Completed Creatine Therapy for Huntington's Disease
Condition: Huntington's Disease
Intervention: Drug: Creatine
24 Completed A Study of the Novel Drug Dimebon in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Other: Placebo;   Drug: Dimebon
25 Completed Bioavailability of Ubiquinol in Huntington Disease
Condition: Huntington Disease
Intervention: Dietary Supplement: ubiquinol
26 Unknown  Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN)
Condition: Huntington Disease
Intervention:
27 Completed Working Memory Training in Huntington's Disease
Condition: Huntington's Disease
Intervention: Behavioral: Cogmed QM
28 Completed Family Health After Predictive Huntington Disease (HD) Testing
Condition: Huntington Disease
Intervention: Genetic: Mutation in the gene
29 Recruiting Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-HTTRx in Patients With Early Manifest Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: IONIS HTTRx;   Drug: Placebo
30 Terminated
Has Results
Coenzyme Q10 in Huntington's Disease (HD)
Condition: Huntington's Disease
Interventions: Drug: coenzyme Q10;   Other: placebo
31 Completed Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study
Condition: Huntington's Disease
Intervention: Drug: Creatine Monohydrate
32 Not yet recruiting Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease
Condition: Huntington Disease
Interventions: Other: Cellavita HD lower dose;   Other: Cellavita HD intermediate dose;   Other: Cellavita HD Higher dose
33 Completed Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability
Condition: Huntington's Disease
Intervention: Drug: Creatine monohydrate
34 Completed A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease
Condition: Huntington's Disease
Intervention: Drug: SEN0014196
35 Recruiting Growth and Development of the Striatum in Huntington's Disease
Condition: Huntington's Disease
Intervention:
36 Completed An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196
Condition: Huntington Disease
Interventions: Drug: SEN0014196 (Low Dose);   Drug: SEN0014196 (High Dose);   Drug: Placebo
37 Recruiting Resveratrol and Huntington Disease
Condition: Huntington Disease
Interventions: Dietary Supplement: Resveratrol;   Other: Placebo
38 Completed A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Versus Placebo for Symptomatic Treatment in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: Pridopidine;   Other: Placebo
39 Completed Deep Brain Stimulation of the Globus Pallidus in Huntington's Disease
Condition: Huntington's Disease
Intervention: Procedure: Stimulation
40 Completed Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)
Condition: Huntington's Disease
Intervention: Drug: sodium phenylbutyrate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.